EUCTR2005-004933-16-DK进行中（未招募）不适用
The effect of high dose Simvastatine on Multiple Myeloma
Department of Haematology0 个研究点目标入组 10 人开始时间: 2005年11月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Multiple myleoma-patients in need of treatment. I.e. with symptoms and/or measurable organ-impairment.
- •The patients might have stable or progressive disease and ongoing treatment for the disease may continue unchanged during the course of the trial.
- •Patients must be18 years or older
- •Patients must have performance status < 3
- •Patients must have life expectancy > 3 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients incapable af giving concent personally
- •Renal insufficiens with creatinine clearence below 25 ml/min
- •Other active malignant disease than multiple myeloma
- •Alanine aminotransferasis > 2,5 upper reference limit
- •Thyroxine below lower reference limit
- •Known familiar muscle-disease or previous myopati after statin or fibrate treatment
- •Creatine kinase > 10 x upper reference limit before treatment
- •Chronic alkoholisme
- •Medication with drugs with known interactions with simvastatin
- •Allergy to simvastatin or other substances in the drug
研究者
相似试验
进行中（未招募）
不适用
The effect of long-term simvastatin treatment on cognitive function and daily life in children with Neurofibromatosis 1: a one year randomized controlled trialeurofibromatosis 1EUCTR2009-010965-22-NLErasmus MC - Department of Pediatrics106
尚未招募
2 期
Efficacy of add-on high-dose simvastatin on markers for disease progression in MS patients treated with ocrelizumab and natalizumab (SIMSON), a phase II clinical trial.Multiple sclerosis10012303MSNL-OMON49976Vrije Universiteit Medisch Centrum100
进行中（未招募）
1 期
Research on the effect of add-on high dosage simvastatin treatment on progression in MS patients treated with ocrelizumab and natalizumab.Multiple sclerosisEUCTR2019-003127-38-NLVUmc Neurology Department100
进行中（未招募）
不适用
Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoidEUCTR2011-004361-32-DEPhilipps-Universität Marburg
进行中（未招募）
2 期
Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoidA prospective multi-centre randomised double-blind placebo-controlled pilot studyL12.0Bullous pemphigoidDRKS00003851Philipps-Universität Marburg1